A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease.
PMID:35889336
Expediting knowledge acquisition by a web framework for Knowledge Graph Exploration and Visualization (KGEV): case studies on COVID-19 and Human Phenotype Ontology.
PMID:35655307
Discovery of new drug indications for COVID-19: A drug repurposing approach.
PMID:35609015
Design and application of a knowledge network for automatic prioritization of drug mechanisms.
PMID:35561182
Applying polypharmacology approach for drug repurposing for SARS-CoV2.
PMID:35498548
Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer.
PMID:35205629
Exploring complex and heterogeneous correlations on hypergraph for the prediction of drug-target interactions.
PMID:34950907
Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer.
PMID:34888523
Using predictive machine learning models for drug response simulation by calibrating patient-specific pathway signatures.
PMID:34707117
NCATS Inxight Drugs: a comprehensive and curated portal for translational research.
PMID:34648031
A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma.
PMID:34592158
PPI-MASS: An Interactive Web Server to Identify Protein-Protein Interactions From Mass Spectrometry-Based Proteomics Data.
PMID:34277709
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
PMID:34159484
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach.
PMID:34125422
Target identification among known drugs by deep learning from heterogeneous networks.
PMID:34123272
Predicting anticancer hyperfoods with graph convolutional networks.
PMID:34099048
Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study.
PMID:34067485
Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19.
PMID:34056406
NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study.
PMID:33907758
Integrative Data Analytic Framework to Enhance Cancer Precision Medicine.
PMID:33796878
Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.
PMID:33787872
Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
PMID:33589624
InContext: curation of medical context for drug indications.
PMID:33579375
Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches.
PMID:33437151
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.
PMID:33431024
Towards reproducible computational drug discovery.
PMID:33430992
Network machine learning maps phytochemically rich "Hyperfoods" to fight COVID-19.
PMID:33386081
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19.
PMID:33330842
The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
PMID:33205077
REDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 Activities.
PMID:33200119
KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response.
PMID:33196056
High intensity interval training exercise-induced physiological changes and their potential influence on metabolic syndrome clinical biomarkers: a meta-analysis.
PMID:33172413
DrugCentral 2021 supports drug discovery and repositioning.
PMID:33151287
High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein.
PMID:33103586
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak.
PMID:32972027
KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response.
PMID:32839776
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies.
PMID:32787328
Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing.
PMID:32657387
Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
PMID:32611313
Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors.
PMID:32371905
Non-Negative Matrix Factorization for Drug Repositioning: Experiments with the repoDB Dataset.
PMID:32308816
Wikidata as a knowledge graph for the life sciences.
PMID:32180547
Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.
PMID:31950972
DDI-PULearn: a positive-unlabeled learning method for large-scale prediction of drug-drug interactions.
PMID:31870276
Evaluating the consistency of large-scale pharmacogenomic studies.
PMID:31846027
Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
PMID:31829175
An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology.
PMID:31823145
A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome.
PMID:31740673
Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations.
PMID:31612362
A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments.
PMID:31546814
CDEK: Clinical Drug Experience Knowledgebase.
PMID:31411687
Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz.
PMID:31372215
A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria.
PMID:31360332
Exploring the dark genome: implications for precision medicine.
PMID:31270560
HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods.
PMID:31270435
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR.
PMID:31244651
The human endogenous metabolome as a pharmacology baseline for drug discovery.
PMID:31226432
GenCoNet - A Graph Database for the Analysis of Comorbidities by Gene Networks.
PMID:30864352
Free Accessible Databases as a Source of Information about Food Components and Other Compounds with Anticancer Activity⁻Brief Review.
PMID:30813234
Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.
PMID:30696729
Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases.
PMID:30690196
Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases.
PMID:30598065
DrugCentral 2018: an update.
PMID:30371892
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.
PMID:30359818
Network-Based Methods for Prediction of Drug-Target Interactions.
PMID:30356768
Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.
PMID:30319692
Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation.
PMID:30303482
Editorial: Drug Repositioning: Current Advances and Future Perspectives.
PMID:30294274
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets.
PMID:30190791
Computational resources associating diseases with genotypes, phenotypes and exposures.
PMID:30102366
A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction.
PMID:30061691
A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products.
PMID:29982512
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center.
PMID:29917015
Changing Trends in Computational Drug Repositioning.
PMID:29874824
Exploiting semantic patterns over biomedical knowledge graphs for predicting treatment and causative relations.
PMID:29763706
The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity.
PMID:29631359
Drug Repositioning in Glioblastoma: A Pathway Perspective.
PMID:29615902
Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs.
PMID:29541361
Unexplored therapeutic opportunities in the human genome.
PMID:29472638
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
PMID:29149325
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.
PMID:29140520
SuperDRUG2: a one stop resource for approved/marketed drugs.
PMID:29140469
Drug target ontology to classify and integrate drug discovery data.
PMID:29122012
Formalizing drug indications on the road to therapeutic intent.
PMID:29016968
Evidence-Based Precision Oncology with the Cancer Targetome.
PMID:28964549
Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
PMID:28936969
A standard database for drug repositioning.
PMID:28291243
Protein biomarker druggability profiling.
PMID:28131723
Pharos: Collating protein information to shed light on the druggable genome.
PMID:27903890